Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Placebo Evaluate”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT04417972
What this trial is testing

The Pharmacokinetic(PK)/Pharmacodynamics(PD) Study of SHR7280 Tablets in Premenopausal Subjects With Endometriosis.

Who this might be right for
Endometriosis
Jiangsu HengRui Medicine Co., Ltd. 179
Testing effectiveness (Phase 2)Looking for participantsNCT07519395
What this trial is testing

Investigate Abdominal Symptoms With Camlipixant Compared With Placebo in Adults With Irritable Bowel Syndrome - Diarrhea (IBS-D) and Irritable Bowel Syndrome - Mixed (IBS-M)

Who this might be right for
Irritable Bowel Syndrome
GlaxoSmithKline 420
Testing effectiveness (Phase 2)Study completedNCT03728634
What this trial is testing

Evaluate the Safety and Tolerability, as Well as the Pharmacokinetic and Pharmacodynamic Profiles of Single and Multiple Doses of Eplontersen Administered Subcutaneously to Healthy Volunteers and Patients With Hereditary Transthyretin-Mediated Amyloidosis (hATTR ).

Who this might be right for
Healthy VolunteershATTR Amyloidosis
Ionis Pharmaceuticals, Inc. 47
Large-scale testing (Phase 3)Ended earlyNCT00858364
What this trial is testing

Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy

Who this might be right for
Non-Small Cell Lung CancerAnemiaCancer+1 more
Amgen 2,549
Testing effectiveness (Phase 2)Study completedNCT00690716
What this trial is testing

The Effect of Nasal Carbon Dioxide (CO2) in the Treatment of Mild Headache in People Who Experience Migraines

Who this might be right for
Migraine
Capnia, Inc. 292
Large-scale testing (Phase 3)Study completedNCT00162240
What this trial is testing

PPAR - Combination With Metformin

Who this might be right for
Diabetes Mellitus
Bristol-Myers Squibb 534
Early research (Phase 1)Study completedNCT01219140
What this trial is testing

Pomegranate Extract Biomarker Study in Osteopenic Women

Who this might be right for
Osteopenic Women
POM Wonderful LLC 64
Very early researchLooking for participantsNCT07577817
What this trial is testing

Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of CTX001 in Healthy Adults.

Who this might be right for
AnemiaIron DeficienciesChronic Kidney Disease
Cajal Therapeutics Inc. 72
Early research (Phase 1)Study completedNCT04187560
What this trial is testing

Safety and Tolerability of Single and Multiple Doses of LB-102 in Healthy Adults

Who this might be right for
Schizophrenia
LB Pharmaceuticals Inc. 64
Testing effectiveness (Phase 2)Study completedNCT05576623
What this trial is testing

Safety and Immunogenicity of AdCLD-CoV19-1 OMI as a Booster: A SARS-CoV-2 (COVID-19) Preventive Vaccine

Who this might be right for
COVID-19Vaccines
Cellid Co., Ltd. 320
Large-scale testing (Phase 3)WithdrawnNCT05157243
What this trial is testing

Trial to Evaluate Nitazoxanide for Treatment of Mild or Moderate COVID-19 in Subjects at High Risk of Severe Illness

Who this might be right for
COVID-19
Romark Laboratories L.C.
Large-scale testing (Phase 3)Study completedNCT03930615
What this trial is testing

Extension of Letermovir (LET) From Day 100 to Day 200 Post-transplant for the Prevention of Cytomegalovirus (CMV) Infection in Hematopoietic Stem Cell Transplant (HSCT) Participants (MK-8228-040)

Who this might be right for
Cytomegalovirus Infection
Merck Sharp & Dohme LLC 220
Testing effectiveness (Phase 2)Study completedNCT01972217
What this trial is testing

Ph II Study to Evaluate Olaparib With Abiraterone in Treating Metastatic Castration Resistant Prostate Cancer.

Who this might be right for
Metastatic Castration-resistant Prostate Cancer
AstraZeneca 158
Testing effectiveness (Phase 2)Ended earlyNCT03831191
What this trial is testing

LY3375880 in Adults With Moderate-to-Severe Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Eli Lilly and Company 136
Testing effectiveness (Phase 2)Study completedNCT01583582
What this trial is testing

Antihypertensive Effect and Safety of Peptides Derived From Coldwater Shrimp

Who this might be right for
HypertensionBlood Pressure
Marealis AS 74
Post-approval studies (Phase 4)Study completedNCT00648596
What this trial is testing

Evaluate Self-esteem and Relationships in Males With Erectile Dysfuntion

Who this might be right for
Erectile Dysfunction
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 780
Post-approval studies (Phase 4)Ended earlyNCT00763685
What this trial is testing

Study to Evaluate the Efficacy of Pre-operative Administration of Etoricoxib 120 mg, Etoricoxib 120 mg and Paracetamol 1 g Combination or Placebo in the Treatment of Postoperative Pain in Patients Undergoing Gynaecologic Laparoscopic Surgery

Who this might be right for
Pain
East Tallinn Central Hospital 40
Not applicableNot Yet RecruitingNCT07558525
What this trial is testing

Evaluation of Chiglitazar Sodium With Lifestyle Intervention for Reversing Prediabetes

Who this might be right for
Prediabetes
Second Xiangya Hospital of Central South University 472
Early research (Phase 1)Ended earlyNCT00707590
What this trial is testing

Safety Study to Evaluate BMS-767778 in Healthy Subjects and Subjects With Type 2 Diabetes Mellitus (T2DM)

Who this might be right for
Type 2 Diabetes Mellitus
Bristol-Myers Squibb 120
Large-scale testing (Phase 3)Ended earlyNCT02547220
What this trial is testing

Study to Evaluate the Efficacy and Safety of Cinryze® for the Treatment of Acute Antibody-mediated Rejection in Participants With Kidney Transplant

Who this might be right for
Acute Antibody-Mediated Rejection (AMR)
Shire 39
Next Page